Sponsored by
This is an exciting project that could quickly lead to a new clinical trial for DIPG!
Hewlett, NY 6/21/2018 - The Musella Foundation announced that it has awarded 1 $27,000 brain tumor research grant to Mariella G. Filbin, MD PhD at Dana-Farber Cancer Institute for the project: Inducing therapeutic differentiation in DIPG by re-programming chromatin with dual HDAC/LSD1 inhibition.
This grant is part of the DIPG All-In-Initiative!
About the Musella Foundation
The Musella Foundation For Brain Tumor Research & Information, Inc is a 501(c)3 non- profit organization dedicated to speeding up the search for the cure of brain tumors, as well as helping families deal with the diagnosis of brain cancer, by funding innovative brain tumor research, education, advocacy, emotional and financial support for families that are dealing with brain tumors and organizing the brain tumor community to work together as an army to fight the disease.
Contact: Al Musella, DPM
President Musella Foundation For Brain Tumor Research & Information, Inc
Hewlett, NY 11557
musella@virtualtrials.com